To determine whether CXCL12 participate in FGFR2+ fibrocyte recruitment, we first established whether a CXCL12 gradient existed between ESCC tumor mass and peripheral blood by ELISA. This evidence concerns the gene FGFR2 and esophageal squamous cell carcinoma.